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ABSTRACT
Text S1: Further details on data extraction and MIM-ICD10 mappings
Genetic disease associations are extracted from the Online Mendelian Inheritance in Man (OMIM) dataset, from which we
obtained a list of 4,847 associations between disorders (phenotype MIM numbers) and genes1. Thereby we included only those
phenotype-gene associations for which the molecular basis of the disorder is known (i.e. a phenotype mapping key with value
3 in the OMIM dataset). Metabolic disease associations stem from the UniProtKB database, which provides a list of 3,020
proteins that are known to be involved in disorders in humans (given by phenotype MIM numbers)2. The REACTOME database
cross-references these proteins with pathways in which they occur3. Toxicogenomic disease associations are obtained from the
Comparative Toxicogenomic Database as a list of 4,925 associations between disorders (phenotype MIM numbers or MeSH
ID) and chemicals4. Here we only use curated disease-chemical associations, i.e. those for which direct, literature-curated
evidence exists.
To obtain mappings from MIM phenotype numbers and MeSH codes to the ICD10 classification we compile three different
data sources. In addition to the Human Disease Ontology database5 and mappings provided from OrphaNet6, we extracted
mappings by crawling a disease index page from Wikipedia (https://en.wikipedia.org/wiki/ICD-10, retrieved 04/30/2015). From
these three sources result 85,303 MeSH-ICD10 and 5,498 MIM-ICD10 associations. Aggregated to the three-digit ICD10
level, 90% of the ICD10 codes can be mapped to MeSH codes and 37% to MIM numbers. This lower number of successfully
translated MIM numbers is partly due to the fact that not for all diseases a molecular basis is known or even relevant.
While the ICD10 codes are primarily used for billing and clinical purposes, the OMIM classification focuses on descriptive
phenotypes of inherited conditions. From this follows the limitation that some very specific OMIM codes might link to highly
unspecific ICD10 codes and vice versa. For instance, colorectal cancer has one MIM number (114500) but four different ICD10
codes on the three-digit level, C18-C21. These four phenotypes are not only connected among each other; each disease that is
genetically linked to colorectal cancer is also linked to all four of these ICD10 codes. Consequently the diagnoses C18-C21
have the highest degrees in the genetic comorbidity network. Similarly, the ICD10 codes for essential hypertension (I10-I13)
all map to a single MIM number and have the highest degrees in the toxicogenomic disease network. We therefore adjusted for
such biases by re-scaling the relative comorbidity risk rαi by the node degree k
α
i .
Text S2: Broad-sense heritability
Heritability is a measure that quantifies how much variation in a phenotypic trait (such as a disease) in a population is due to
genetic variation among individuals in the population. More specifically, if σG is the genetic variation and σP the variation in
the population, the broad-sense heritability, H2, is defined as H2 = σGσP . Sloppily defined, heritability measures the proportion
of (disease) risk that is due to the genetic background of an individual, as opposed to environmental factors. However, high
values of heritability do not necessarily imply a high disease risk, as it may be relatively easy to prevent certain genetic diseases
by certain interventions.
Table 1. Overview of characteristics of the HDMN layers. The numbers of non-isolated nodes, Nα , and links, Lα , are given
for four different layers.
α Nα Lα
phenotypic 358 63903
genetic 285 969
pathway-based 251 3930
toxicogenomic 199 4994
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Figure 1. Classification of diseases (circles) according to the dominant contributions to their phenotypic comorbidities for an
alternative definition of the re-scaled relative comorbidity risks, qαi , where two diseases can at the same be comorbid in a
genetic of pathway-based / toxicogenomic way. Again, most diseases cluster around one of the axis with a clear dominance of
genetic comorbidity risks.
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